OMERACT 2006 PsA Core Domain Set | OMERACT 2014 Voted (≥ 70%) Inclusion in the Core Set | Draft Core Domain Set at the End of the NGT Meeting 2016 | Draft Core Set after the Second Patient and Physician Survey* |
---|---|---|---|
Peripheral joint activity | Dactylitis | MSK disease activity | MSK disease activity |
Skin activity | Skin disease activity | Skin disease activity | |
Pain | Pain | Pain | |
Patient global | PtGA | PtGA | |
Physical function | Physical function | Physical function | |
HRQOL | |||
Participation | Participation | ||
Emotional well-being | |||
Fatigue | Fatigue | Fatigue | |
Systemic inflammation | Systemic inflammation | ||
Structural damage ** | Structural damage ** |
↵* During the second survey, patients and physicians rated the importance of domains proposed after the NGT meeting – emotional well-being was moved out of the core because less than 70% of either physician or patient respondents rated it as at least 8 on a scale from 0–10.
↵** Structural damage was recommended for assessment at least once during the development of a new drug for PsA. PsA: psoriatic arthritis; OMERACT: Outcome Measures in Rheumatology; NGT: nominal group technique; HRQOL: health-related quality of life; MSK: musculoskeletal; PtGA: patient’s global assessment.